Abreva
Abreva Brand names, Abreva Analogs
Abreva Brand Names Mixture
- No information avaliable
Abreva Chemical_Formula
C21H28O2
Abreva RX_link
No information avaliable
Abreva fda sheet
Abreva msds (material safety sheet)
Abreva Synthesis Reference
No information avaliable
Abreva Molecular Weight
312.446 g/mol
Abreva Melting Point
169.5 oC
Abreva H2O Solubility
No information avaliable
Abreva State
Solid
Abreva LogP
3.86
Abreva Dosage Forms
Tablets for oral administration (10mg)
Abreva Indication
Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.
Abreva Pharmacology
Dydrogesterone is an orally active progestogen which acts directly on the uterus, producing a complete secretory endometrium in an estrogen-primed uterus. At therapeutic levels, dydrogesterone has no contraceptive effect as it does not inhibit or interfere with ovulation or the corpus luteum. Furthermore, dydrogesterone is non-androgenic, non-estrogenic, non-corticoid, non-anabolic and is not excreted as pregnanediol. Dydrogesterone helps to regulate the healthy growth and normal shedding of the uterus lining. Therefore, it may be useful in the treatment of menstrual disorders such as absent, irregular or painful menstrual periods, infertility, premenstrual syndrome and endometriosis.
Abreva Absorption
Rapidly absorbed in the gastrointestinal tract.
Abreva side effects and Toxicity
No information avaliable
Abreva Patient Information
No information avaliable
Abreva Organisms Affected
Humans and other mammals
